Primary |
Osteoporosis |
70.2% |
Rheumatoid Arthritis |
6.0% |
Osteitis Deformans |
3.2% |
Osteoporosis Prophylaxis |
3.2% |
Hypertension |
2.8% |
Osteoporosis Postmenopausal |
2.5% |
Osteopenia |
2.1% |
Back Pain |
1.1% |
Depression |
1.1% |
Gastric Ulcer |
1.1% |
Gastritis |
1.1% |
Hyperlipidaemia |
1.1% |
Constipation |
0.7% |
Interstitial Lung Disease |
0.7% |
Prophylaxis Against Gastrointestinal Ulcer |
0.7% |
Respiratory Disorder |
0.7% |
Spinal Osteoarthritis |
0.7% |
Ulcer |
0.7% |
Antibiotic Prophylaxis |
0.4% |
Arthralgia |
0.4% |
|
Pathological Fracture |
13.9% |
Femur Fracture |
11.1% |
Stress Fracture |
8.3% |
Malaise |
6.5% |
White Blood Cell Count Decreased |
6.5% |
White Blood Cell Count Increased |
6.5% |
Pyrexia |
5.6% |
Atypical Femur Fracture |
4.6% |
Pain In Extremity |
4.6% |
Tooth Extraction |
4.6% |
Interstitial Lung Disease |
3.7% |
Osteonecrosis |
3.7% |
Cerebral Infarction |
2.8% |
Red Blood Cell Count Decreased |
2.8% |
Skin Ulcer |
2.8% |
Toothache |
2.8% |
Trismus |
2.8% |
Urticaria |
2.8% |
Blood Alkaline Phosphatase Increased |
1.9% |
Bone Callus Excessive |
1.9% |
|
Secondary |
Osteoporosis |
20.8% |
Migraine |
12.2% |
Product Used For Unknown Indication |
11.7% |
Osteoarthritis |
9.4% |
Rheumatoid Arthritis |
6.7% |
Asthma |
5.8% |
Hypertension |
5.1% |
Drug Use For Unknown Indication |
5.0% |
Deep Vein Thrombosis |
2.8% |
Epilepsy |
2.7% |
Hypothyroidism |
2.7% |
Ill-defined Disorder |
2.2% |
Osteoporosis Postmenopausal |
1.9% |
Pain |
1.8% |
Prostate Cancer |
1.8% |
Osteoporosis Prophylaxis |
1.7% |
Back Pain |
1.6% |
Prophylaxis |
1.5% |
Hyperchlorhydria |
1.4% |
Irritable Bowel Syndrome |
1.4% |
|
Femur Fracture |
22.2% |
Dyspnoea |
13.2% |
Stress Fracture |
7.6% |
Panic Attack |
6.9% |
Syncope |
5.6% |
Cerebrovascular Accident |
4.9% |
Vomiting |
4.9% |
Low Turnover Osteopathy |
4.2% |
Atrial Fibrillation |
3.5% |
Osteonecrosis |
3.5% |
Impaired Healing |
2.8% |
Liver Disorder |
2.8% |
Transient Ischaemic Attack |
2.8% |
Wheezing |
2.8% |
Arthralgia |
2.1% |
Helicobacter Pylori Identification Test Positive |
2.1% |
Myalgia |
2.1% |
Oesophageal Ulcer |
2.1% |
Off Label Use |
2.1% |
Osteomyelitis |
2.1% |
|
Concomitant |
Drug Use For Unknown Indication |
35.8% |
Rheumatoid Arthritis |
24.1% |
Product Used For Unknown Indication |
9.6% |
Osteoporosis |
7.6% |
Prophylaxis |
4.1% |
Hypertension |
3.8% |
Pain |
2.3% |
Asthma |
1.5% |
Constipation |
1.4% |
Vitamin Supplementation |
1.2% |
Crohn's Disease |
1.2% |
Depression |
1.1% |
Diabetes Mellitus |
1.0% |
Osteoporosis Prophylaxis |
1.0% |
Prophylaxis Against Gastrointestinal Ulcer |
0.9% |
Insomnia |
0.8% |
Gastrooesophageal Reflux Disease |
0.7% |
Gastritis Prophylaxis |
0.7% |
Hyperlipidaemia |
0.7% |
Arthritis |
0.7% |
|
Pneumonia |
9.3% |
Vomiting |
7.3% |
Sepsis |
7.1% |
Pyrexia |
6.8% |
Death |
5.4% |
Interstitial Lung Disease |
5.4% |
Urinary Tract Infection |
5.4% |
Nausea |
5.1% |
White Blood Cell Count Decreased |
4.9% |
Rheumatoid Arthritis |
4.6% |
Vasculitis |
4.6% |
Pain In Extremity |
4.4% |
Weight Decreased |
4.4% |
Myocardial Infarction |
4.2% |
Palpitations |
3.9% |
Incorrect Dose Administered |
3.4% |
Pain |
3.4% |
Polymyositis |
3.4% |
Pulmonary Embolism |
3.4% |
Rash |
3.4% |
|
Interacting |
Osteoporosis |
22.7% |
Hypertension |
18.2% |
Dyslipidaemia |
9.1% |
Pain |
9.1% |
Prophylaxis Against Gastrointestinal Ulcer |
9.1% |
Restless Legs Syndrome |
9.1% |
Secondary Hyperthyroidism |
9.1% |
Type 2 Diabetes Mellitus |
9.1% |
Furuncle |
4.5% |
|
Transaminases Increased |
66.7% |
Oesophagitis |
33.3% |
|